Felicity E. Groth

Partner

Philadelphia
T +1.215.564.8978
F +1.215.568.3439

Overview

Felicity Groth is a partner in BakerHostetler’s Intellectual Property Group with more than 20 years of experience in global life sciences patent strategy and counseling. She advises domestic and international clients on the strategic development of complex worldwide patent portfolios, product development and clearance strategies, and lifecycle development. Her clients look to Felicity for support of their large molecule development from conception to launch to post-market activity.

With an extensive background in the life sciences arena, Felicity works closely with clients to understand and facilitate their evolving business goals through strategic IP planning and implementation. She assists clients in developing and implementing effective strategies to enhance IP rights and mitigate IP risks, thereby building strong patent portfolios that protect and promote commercialization of both platform technologies and biological products. She concentrates on the fields of biotechnology, enzymology, genomics, molecular biology, microbiology, immunology and biochemistry, with a focus on nucleic acid-, cell- and protein-based therapeutics and diagnostics, formulations and manufacturing technologies. 

Select Experience

  • Develops and implements global IP strategy for specialty branded pharmaceutical company in orthopedic, men’s health and medical aesthetics spaces.
  • Represents a leading global research and development-based pharmaceutical company in developing and implementing IP strategy around multiple therapeutic antibodies with focus on therapeutic areas with high unmet medical needs, including oncology and neurology.
  • Assists a major biotechnology company in strategic business decision-making by providing patentability, freedom to operate and patent validity analyses and in considering potentially infringing competitor activity.
More »

Experience

  • Develops and implements global IP strategy for specialty branded pharmaceutical company in orthopedic, men’s health and medical aesthetics spaces.
  • Represents a leading global research and development-based pharmaceutical company in developing and implementing IP strategy around multiple therapeutic antibodies with focus on therapeutic areas with high unmet medical needs, including oncology and neurology.
  • Assists a major biotechnology company in strategic business decision-making by providing patentability, freedom to operate and patent validity analyses and in considering potentially infringing competitor activity.
  • Provides global portfolio management and advice for biotechnology company focused on design of DNA medicines including DNA vaccines, DNA immunotherapies, and DNA-encoded monoclonal antibodies to treat, cure, and protect people from cancer and infectious disease.
  • Works closely with biotechnology startups and licensor institutions to develop and implement an effective IP strategy focused on treatment of cancer and chronic infections.

Recognitions and Memberships

Recognitions

  • The Best Lawyers in America® (2020 to Present)
    • Pennsylvania: Patent Law
  • Pennsylvania Super Lawyers "Rising Star" (2006 to 2007)

Memberships

  • Philadelphia Intellectual Property Law Association
    • Immediate Past President (2019 to 2020)
    • President (2018 to 2019)
    • President-elect (2017 to 2018)
    • Vice President (2016 to 2017)
    • Secretary (2014 to 2016)
    • Board Member (2010 to 2012)
  • Life Sciences Pennsylvania
  • ChIPs, Philadelphia Chapter

Industries

Prior Positions

  • Woodcock Washburn LLP: Attorney Advisor

Admissions

  • U.S. Patent and Trademark Office, Registration No. 47,042
  • Pennsylvania

Education

  • J.D., University of Pennsylvania Law School, 2000, with legal writing honors
  • M.S., Biochemistry, University of Pennsylvania, 1997
  • B.S., Biochemistry, The Pennsylvania State University, 1995